Potential of nanoliposomes for the therapy and/or diagnosis of Alzheimer’s disease: recent progress

References

• Antimisiaris SG, Mourtas S, Markoutsa E et al. Nanoparticles for diagnosis and/or treatment of Alzheimer’s disease. In: Advanced Healthcare Materials. Tiwari A (Ed.). John Wiley & Sons, Inc. NJ, USA, Chapter 4 (2014).
   Google Scholar
• Wong HL, Wu XY, Bendayan R, Nanotechnological advances for the delivery of CNS therapeutics. Adv. Drug Deliv. Rev. 64, 686–700 (2012).
   Google Scholar
• Le Droumaguet B, Nicolas J, Brambilla D et al. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer’s disease. ACS Nano 6, 5866–5879 (2012).
   Google Scholar
• National Institute of Aging: about Alzheimer’s disease, Alzheimer’s basics. www.nia.nih.gov/alzheimers/topics/alzheimers-basics
   Google Scholar
• Klafki HW, Staufenbiel M, Kornhuber J et al. Therapeutic approaches to Alzheimer’s disease. Brain 129, 2840–2855 (2006).
   Google Scholar
• Pardridge WM, The blood–brain barrier: bottleneck in brain drug development. NeuroRx 2, 3–14 (2005).
   Google Scholar
• Lazar A, Mourtas S, Youssef I et al. Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease. Nanomed. 9, 712–721 (2013).
   Google Scholar
• Alzforum. ‘EU Consortium Applies Nanotechnology to Study Alzhiemers Disease’ (9 Sep 2011). www.alzforum.org/news/
   Google Scholar
• Papadia K, Markoutsa E, Antimisiaris SG, A simplified method to attach antibodies on liposomes by biotin–streptavidin affinity for rapid and economical screening of targeted liposomes. J. Biomed. Nanotechnol. 10, 871–876 (2014).
   Google Scholar
• Re F, Cambianica I, Zona C et al. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood–brain barrier model. Nanomedicine 7, 551–559 (2011).
   Google Scholar
• Markoutsa E, Papadia K, Giannou AT et al. Mono and dually decorated nanoliposomes for brain targeting in vitro and in vivo studies. Pharm. Res. 31, 1275–1289 (2014).
   Google Scholar
• Salvati A, Pitek AS, Monopoli MP et al. Transferrinfunctionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotech. 8, 137–143 (2013).
   Google Scholar
• Markoutsa E, Pampalakis G, Niarakis A et al. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line. Eur. J. Pharm. BioPharm. 77, 265–274 (2011).
   Google Scholar
• Re F, Airoldi C, Zona C et al. Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer’s disease. Curr. Med. Chem. 17, 2990–3006 (2010).
   Google Scholar
• Canovi M, Markoutsa E, Lazar AN et al. The binding affinity of anti-Aβ1–42 MAb-decorated nanoliposomes to Aβ1–42 peptides in vitro and to amyloid deposits in post-mortem tissue. Biomaterials 32, 5489–5497 (2011).
   Google Scholar
• Mourtas S, Canovi M, Zona C et al. Curcumin-decorated nanoliposomes with very high affinity for amyloid-b1–42 peptide. Biomaterials 32, 1635–1645 (2011).
   Google Scholar
• Taylor M, Moore S, Mourtas S et al. Effect of curcuminassociated and lipid-ligand functionalised nanoliposomes on aggregation of the Alzheimer’s Aβ peptide. Nanomed. 7, 541–550 (2011).
   Google Scholar
• Mourtas S, Lazar AN, Markoutsa E, Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur. J. Med. Chem. 80, 175–183 (2014).
   Google Scholar
• Gobbi M, Re F, Canovi M et al. Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide. Biomaterials 31, 6519–6529 (2010).
   Google Scholar
• Bereczki E, Re F, Masserini M et al. Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells. Nanomedicine 7, 560–571 (2011).
   Google Scholar
• Markoutsa E, Papadia K, Clemente C et al. Anti-Aβ MAb and dually-decorated nanoliposomes: effect of Aβ1–42 peptides on interaction with hCMEC/D3 cells. Eur. J. Pharm. Biopharm. 81, 49–56 (2012).
   Google Scholar
• Skouras A, Mourtas S, Markoutsa E et al. USPIO encapsulating nanoliposomes with high entrapping efficiency, stability and magnetic properties. Nanomedicine 7, 572–579 (2011).
   Google Scholar